
    
      The primary objective is to evaluate the safety and effectiveness of 3 weekly IA doses of 2
      mL of hyaluronate viscosupplement as compared to placebo injected into the target knee for
      the treatment of pain in subjects with OA As secondary objectives, the study will evaluate
      the safety and effectiveness of 3 weekly IA doses of 2 mL of Viscosupplement as compared to
      Euflexxa injected into the target knee for the treatment of pain in subjects with OA. In
      addition, to assess the effect of Viscosupplement on pain, stiffness, and physical function
      of the target knee, as well as functional health and general well-being
    
  